Boothbay Fund Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-71,300
Closed -$7.59M 2108
2023
Q1
$7.59M Buy
+71,300
New +$7.7M 0.16% 126
2022
Q4
Sell
-5,300
Closed -$456K 2283
2022
Q3
$456K Sell
5,300
-124,400
-96% -$11.1M 0.01% 1279
2022
Q2
$11.8M Buy
129,700
+119,000
+1,112% +$10.5M 0.31% 34
2022
Q1
$878K Buy
+10,700
New +$844K 0.02% 974
2019
Q1
Sell
-99
Closed -$718K 834
2018
Q4
$718K Buy
+99
New +$6.99K 0.1% 200

Other funds holding MRK

Boothbay Fund Management's MRK Position: Q2 2026 in Review

Boothbay Fund Management sold out of Merck (MRK) in Q2 2026, closing a stake of 25,244 shares — an estimated $3.04M sold.

Boothbay Fund Management first reported a position in MRK in Q1 2015 and held it in 32 quarters. The position peaked at $23.5M in Q1 2023. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Boothbay Fund Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 25,244 Merck shares in Q2 2026, an estimated $3.04M.
  • Boothbay Fund Management first reported a position in Merck in Q1 2015 and held it in 32 quarters.
  • Boothbay Fund Management's Merck position peaked at $23.5M in Q1 2023.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.